Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Syncona to focus on realisations to return GBP250 million

21st Oct 2025 13:25

Syncona Ltd - London-based investor in life science companies - Sets out results of its strategy review, proposing focus on realisations of mature private companies in its portfolio until it has been able to return up to GBP250 million to shareholders "in a timely manner". The returns, representing about 40% of the company's current market value, could take the form of a tender offer, share buyback, or special dividend, Syncona says.

The portfolio "is funded to deliver 10 key value inflection points over the next three years, with the potential to drive significant NAV growth," the company says. Syncona Investment Management Ltd, the company's advisor, will work with portfolio to deliver these inflection points. SIML also aim to raise a new private fund to invest alongside Syncona to diversify funding sources for those portfolio companies.

Once GBP250 million has been returned to shareholders, Syncona will focus once again on funding new life science investments and existing portfolio companies, it says, aiming for a portfolio of 20 to 25 companies. However, it will no longer seek to grow assets to GBP5 billion by 2032, as was its previous target.

Current stock price: 99.76 pence for GBP606.4 million market capitalisation

12-month change: down 8.5%

By Tom Waite, Alliance News editor

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

Syncona
FTSE 100 Latest
Value9,534.84
Change107.85